XIAP-mediated degradation of IFT88 disrupts HSC cilia to stimulate HSC activation and liver fibrosis

EMBO Rep. 2024 Mar;25(3):1055-1074. doi: 10.1038/s44319-024-00092-y. Epub 2024 Feb 13.

Abstract

Activation of hepatic stellate cells (HSCs) plays a critical role in liver fibrosis. However, the molecular basis for HSC activation remains poorly understood. Herein, we demonstrate that primary cilia are present on quiescent HSCs but exhibit a significant loss upon HSC activation which correlates with decreased levels of the ciliary protein intraflagellar transport 88 (IFT88). Ift88-knockout mice are more susceptible to chronic carbon tetrachloride-induced liver fibrosis. Mechanistic studies show that the X-linked inhibitor of apoptosis (XIAP) functions as an E3 ubiquitin ligase for IFT88. Transforming growth factor-β (TGF-β), a profibrotic factor, enhances XIAP-mediated ubiquitination of IFT88, promoting its proteasomal degradation. Blocking XIAP-mediated IFT88 degradation ablates TGF-β-induced HSC activation and liver fibrosis. These findings reveal a previously unrecognized role for ciliary homeostasis in regulating HSC activation and identify the XIAP-IFT88 axis as a potential therapeutic target for liver fibrosis.

Keywords: Cilium; Hepatic Stellate Cell; Liver Fibrosis; Proteasomal Degradation; Ubiquitination.

MeSH terms

  • Animals
  • Cilia* / metabolism
  • Hepatic Stellate Cells / metabolism
  • Hepatic Stellate Cells / pathology
  • Liver / metabolism
  • Liver Cirrhosis* / chemically induced
  • Liver Cirrhosis* / metabolism
  • Liver Cirrhosis* / pathology
  • Mice
  • Transforming Growth Factor beta / metabolism

Substances

  • Transforming Growth Factor beta
  • Birc4 protein, mouse
  • Tg737Rpw protein, mouse